Literature DB >> 35022564

Imaging characteristics of bilateral CSCR cases:12 months follow up.

Sumit Randhir Singh1, Deepika C Parameswarappa2, Supriya Arora3, Dmitrii S Maltsev4, Niroj Kumar Sahoo5, Alexei N Kulikov4, Claudio Iovino6, Filippo Tatti7, Ramesh Venkatesh8, Nikitha Gurram Reddy8, Ram Snehith Pulipaka8, Enrico Peiretti7, Jay Chhablani9.   

Abstract

PURPOSE: To report the disease pattern, progression and imaging characteristics in eyes with bilateral central serous chorioretinopathy (CSCR).
METHODS: This was a retrospective case review of bilateral CSCR patients with active disease in at least one eye. Multimodal imaging including fundus photography, fundus autofluorescence, optical coherence tomography (OCT), fluorescein and indocyanine angiography (FA/ICGA) was done at baseline and follow-up visits. Disease classification was done using recently described classification criteria. The degree of asymmetry in the disease distribution pattern at baseline and disease progression during follow-up visit with a minimum duration of 12 months was studied.
RESULTS: Among 103 CSCR patients, 36 patients (34.95%) with mean age of 53.6 ± 10.5 years had bilateral CSCR at baseline. Five patients (13.9%) had asymmetrical disease i.e. simple in one eye and complex in fellow eye. The remaining 31 patients had symmetric disease (simple, 2; complex 29). Mean duration of follow up was 17.58 ± 13.84 months. There was no significant difference between both eye parameters at last follow up (best corrected visual acuity, BCVA; central macular thickness, CMT; and subfoveal choroidal thickness, SFCT) (all p > 0.05). At last follow up, 22 eyes (2 simple and 20 complex) remained active whereas none of the eyes converted from simple to complex CSCR.
CONCLUSION: Bilateral disease was more commonly seen with complex CSCR in contrast to simple CSCR. Moreover, disease distribution in complex CSCR had symmetric pattern if bilateral disease was present. None of the simple CSCR eyes converted to complex type.
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Year:  2022        PMID: 35022564     DOI: 10.1038/s41433-021-01885-4

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  13 in total

1.  The time pattern of bilateral exudative age-related macular degeneration.

Authors:  G S Gudnadottir; K P Magnusson; E Stefansson; F Jonasson; G Helgadottir; H Sigurdsson
Journal:  Acta Ophthalmol Scand       Date:  2005-06

2.  Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging.

Authors:  Chandrakumar Balaratnasingam; K Bailey Freund; Anna M Tan; Sarah Mrejen; Alex P Hunyor; David J Keegan; Kunal K Dansingani; Pouya N Dayani; Irene A Barbazetto; David Sarraf; Lee M Jampol; Lawrence A Yannuzzi
Journal:  Ophthalmology       Date:  2016-04-12       Impact factor: 12.079

3.  Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report.

Authors:  Nichole Joachim; Johanna Maria Colijn; Annette Kifley; Kristine E Lee; Gabriëlle H S Buitendijk; Barbara E K Klein; Chelsea E Myers; Stacy M Meuer; Ava G Tan; Elizabeth G Holliday; John Attia; Gerald Liew; Sudha K Iyengar; Paulus T V M de Jong; Albert Hofman; Johannes R Vingerling; Paul Mitchell; Caroline C W Klaver; Ronald Klein; Jie Jin Wang
Journal:  Br J Ophthalmol       Date:  2017-01-20       Impact factor: 4.638

4.  Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.

Authors:  Y T Kim; S W Kang; K H Bai
Journal:  Eye (Lond)       Date:  2011-10-21       Impact factor: 3.775

5.  [Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects].

Authors:  H C Gäckle; G E Lang; K A Freissler; G K Lang
Journal:  Ophthalmologe       Date:  1998-08       Impact factor: 1.059

6.  Discrepancy in current central serous chorioretinopathy classification.

Authors:  Sumit Randhir Singh; Alexandre Matet; Elon H C van Dijk; Alejandra Daruich; Sascha Fauser; Suzanne Yzer; Enrico Peiretti; Sobha Sivaprasad; Andrew J Lotery; Camiel J F Boon; Francine Behar-Cohen; K Bailey Freund; Jay Chhablani
Journal:  Br J Ophthalmol       Date:  2018-07-12       Impact factor: 4.638

Review 7.  Masqueraders of central serous chorioretinopathy.

Authors:  Niroj Kumar Sahoo; Sumit Randhir Singh; Anand Rajendran; Dhananjay Shukla; Jay Chhablani
Journal:  Surv Ophthalmol       Date:  2018-09-20       Impact factor: 6.048

8.  Prevalence and Profile of Central Serous Chorioretinopathy in an Indian Cohort.

Authors:  Niroj Kumar Sahoo; Sumit Randhir Singh; Priyanka Kammari; Ganesh Babu Jonnadula; Anthony Vipin Das; Jay Chhablani
Journal:  Nepal J Ophthalmol       Date:  2019-01

9.  Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY).

Authors:  John R Gonder; Valery M Walker; Martin Barbeau; Nancy Zaour; Bryan H Zachau; James R Hartje; Ruihong Li
Journal:  J Ophthalmol       Date:  2014-03-26       Impact factor: 1.909

Review 10.  Management of chronic central serous chorioretinopathy.

Authors:  Daren Hanumunthadu; Anna C S Tan; Sumit Randhir Singh; Niroj Kumar Sahu; Jay Chhablani
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.